// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Outcomes of Very Small Pediatric Donor Kidneys Utilizing Belatacept-Based Immunosuppression in Adult Recipients

K. Heinen - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Belatacept

Pooled Prevalence of Pulmonary Embolism in Lung Transplant Recipients – A Meta-Analysis

F. Pyarali - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Portal Vein Thrombosis and DCD Liver Transplantation: Dangerous Combination or Clinical Opportunity?

E. Calderon - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Safety and Efficacy of Darbepoetin Alfa Dosing Strategies in Renal Transplant Recipients

J. A. Solis - American Transplant Congress (ATC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Darbepoetin alfa

Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation a systematic review and meta analysis

Qi Zhuang Siah - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Public reporting of outcomes after percutaneous coronary intervention is mortality the best outcome

Matthew Kelham - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Extracellular vesicles in cardiometabolic disorders: from waste product to reliable disease biomarkers

Maria Felice Brizzi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Bilateral adrenal haemorrhages secondary to Rivaroxaban on a background of p-ANCA vasculitis

Mohammad Farhan Malik - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Hydrocortisone

Coagulation parameters in asymptomatic patients with adrenal incidentaloma: is mild autonomous cortisol secretion correlated with thromboembolic risk?

Marianna Minnetti - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Dexamethasone

Resistant Graves’ thyrotoxicosis with adverse cardiovascular effects

Scott Williams - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Levothyroxine

Myxedema coma: case report and literature review

Renata Cassitas Mendona - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hydrocortisone

A case of ChAdOx1 vaccine-induced thrombocytopaenia and thrombosis syndrome leading to bilateral adrenal haemorrhage and adrenal insufficiency

Agathoklis Efthymiadis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Fludrocortisone

Pulmonary thromboembolism as the initial presentation of ACTH-independent Cushing’s Syndrome

Daniela Dias - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydrocortisone

Milk-alkali syndrome in a patient with chronic hypoparathyroidism

Catarina Cidade-Rodrigues - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Slow-K

Diabetic muscle infarction : a case study

Ons Maaoui - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Diabetic muscle infarction: a case study

Ons Maaoui - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Novel pathogenetic mutation of MEN1 gene causing hyperparathyroidism, pancreatic glucagonoma, adrenal adenoma, and collagenomas

Rosa Pitino - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Intranasal glucagon

A rare case of hypocortisolism in hypercoagulable state

Htet Htet Aung - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Glucocorticoid

Acute Left Main Coronary Artery Thrombosis During Exercise Testing

Tudor Sturzoiu - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Acute Myocardial Infarction With Biventricular Thrombi Due to Blunt Thoracic Trauma

Jacob Mok - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

cangrelor

Copyright © 2026. QuantiNova All rights reserved